Laboratory Workup of Amyloidosis.

Area of Science:

• Pathology
• Clinical Diagnostics
• Medical Guidelines

Background:

• Systemic amyloidosis treatments show promise, but early diagnosis and accurate fibril typing are critical.
• Current diagnostic and workup procedures for amyloidosis lack consistency among pathologists and laboratories.
• Inconsistent diagnostic practices can hinder optimal patient care for systemic amyloidosis.

Purpose of the Study:

• To establish evidence-based recommendations for laboratory testing in amyloidosis detection.
• To guide the identification of specific amyloidogenic proteins for improved patient management.
• To optimize patient care through standardized amyloidosis testing and workup protocols.

Main Methods:

• A panel of experts convened by the College of American Pathologists developed guidelines.
• Recommendations were formulated using the National Academy of Medicine's standards for trustworthy clinical practice guidelines.
• A systematic literature review and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework informed the recommendations.

Main Results:

• Four conditional recommendations were established for amyloidosis testing and workup.
• Three good practice statements were developed to guide laboratory procedures.
• The guideline addresses challenges and limitations in diagnosing systemic amyloidosis from tissue samples.

Conclusions:

• The guideline provides essential recommendations for pathologists and laboratories involved in amyloidosis diagnosis.
• Standardized testing and workup are crucial for improving the accuracy of amyloidosis diagnosis.
• Implementing these recommendations aims to enhance patient care and treatment outcomes for systemic amyloidosis.